Cited by 1,163Lipoproteins and Cardiovascular HealthCholesterol and Lipid MetabolismParaoxonase enzyme and polymorphisms

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Open access

Stampfer, Meir J., Sacks, Frank M., Salvini, Simonetta, Willett, Walter C., Hennekens, Charles H.·1991·New England Journal of Medicine

DOI 10.1056/nejm199108083250601

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The independent contributions of subfractions of high-density lipoprotein (HDL) cholesterol (HDL2 and HDL3) and apolipoproteins in predicting the risk of myocardial infarction are unclear. Prospective data are sparse, but HDL2 is widely believed to be a more important predictor than HDL3. METHODS: Blood samples were collected at base line from 14,916 men (ages, 40 to 84 years) who were participants in the Physicians' Health Study. After five years of follow-up, plasma samples from 246 men with new myocardial infarction (case subjects) were analyzed together with specimens from 246 men matched to them for age and smoking status who had not had a myocardial infarction. RESULTS: The levels of total cholesterol and apolipoprotein B-100 were significantly associated with an increased risk of myocardial infarction (data on levels of low-density lipoprotein cholesterol were unavailable). Both HDL cholesterol and HDL2 levels were associated with a substantially decreased risk of myocardial infarction, but the HDL3 level was the strongest predictor; the relative risk was 0.3 (95 percent confidence interval, 0.2 to 0.6) for those in the fifth of the group with the highest HDL3 levels, as compared with the fifth with the lowest levels. The benefit of a higher HDL cholesterol level was most pronounced among those with lower total cholesterol levels. Levels of apolipoprotein A-I and apolipoprotein A-II were also associated with decreased risk. However, the levels of HDL subfractions and apolipoproteins did not add significantly to the value of a multivariate model that included the ratio of total to HDL cholesterol in predicting myocardial infarction, whereas that ratio remained a significant independent predictor of risk. After adjustment for other risk factors, a change of one unit in the ratio of total to HDL cholesterol was associated with a 53 percent change in risk (95 percent confidence interval, 26 percent to 85 percent). CONCLUSIONS: This study underscores the importance of HDL cholesterol in predicting the risk of myocardial infarction and demonstrates protective effects of both the HDL3 and HDL2 subfractions of HDL cholesterol. We found little or no predictive value for the levels of apolipoproteins A-I, A-II, and B or HDL subfractions after conventional risk factors and the ratio of total to HDL cholesterol were considered.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1056/nejm199108083250601

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

From the New York Times Magazine
Minsky, & Hyman, P. (1979) · Cited by 6,899
High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.
Gordon, D. J., Probstfield, J. L., Garrison, R. J., Neaton, J. D., Castelli, W. P., Knoke, J. D., Jacobs, D. R., Bangdiwala, S., & Tyroler, H. A. (1989) · Circulation · doi:10.1161/01.cir.79.1.8 · Cited by 3,162
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
Steering Committee of the Physicians' Health Study Research Group (1989) · New England Journal of Medicine · doi:10.1056/nejm198907203210301 · Cited by 2,267
THE TROMSØHEART-STUDY
Miller, N. E., Thelle, D. S., Førde, O. H., & Mjøs, O. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92274-7 · Cited by 1,206
Separation and quantitation of subclasses of human plasma high density lipoproteins by a simple precipitation procedure
Gidez, L. I., Miller, G. J., Burstein, M., Slagle, S., & Eder, H. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38059-7 · Cited by 757
Ischemic Heart Disease, Atherosclerosis, and Longevity
Gofman, J. W., Young, W., & Tandy, R. K. (1966) · Circulation · doi:10.1161/01.cir.34.4.679 · Cited by 587
Apolipoprotein A-I as a Marker of Angiographically Assessed Coronary-Artery Disease
Maciejko, J. J., Holmes, D. R., Kottke, B. A., Zinsmeister, A. R., Dinh, D. M., & Mao, S. J. T. (1983) · New England Journal of Medicine · doi:10.1056/nejm198308183090701 · Cited by 537
Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. The Expert Panel
Goodman, D. S., Hulley, S. B., Clark, L. T., Davis, C. E., Fuster, V., LaRosa, J. C., Oberman, A., Schaefer, E. J., Steinberg, D., Brown, W. V., et al. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.1.36 · Cited by 529
ARE APOLIPOPROTEINS BETTER DISCRIMINATORS THAN LIPIDS FOR ATHEROSCLEROSIS?
Avogaro, P., Bon, G. B., Avogaro, P., Cazzolato, G., & Quinci, G. B. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91375-8 · Cited by 523

Show all 56 references

Research works printed but not linked: 10

Enger, 1979, Artery, 5, 170
Bennett, 1988, New York Times Magazine, 55
Jones PH, Gotto AM Jr. Assessment of lipid abnormalities. In: Hurst JW, Schlant RC, Rachley CE, Sonnenblick EH, Wenger NK, eds. The heart: arteries and veins. 7th ed. New York: McGraw-Hill, 1990:378–84.
10.1001/archinte.150.8.1645 · DOI
Musliner, 1988, Clin Chem, 34, B78
Hennekens, 1987, Circulation, 76, IV-501
Kempen, 1987, J Lab Clin Med, 109, 19
Avogaro P, Cazzolato G, Bittolo Bon G, Rorai E, Pontoglio E. Lipoprotein derangements in human atherosclerosis. In: Noseda G, Fragiacomo C, Fumagalli R, Paoletti R, eds. Lipoproteins and coronary atherosclerosis. Amsterdam: Elsevier, 1982:123–42.
Kladetzky, 1980, Artery, 7, 191
Desager JP, Rousseau M, Riesen WF, Harvengt C. Limitations of the predictive value for coronary vascular disease of plasma lipids and apoproteins AI, AII, B levels as measured before coronarography in 317 patients. In: de Gennes JL, Polonovski J, Paoletti R, eds. Latent dyslipoproteinemias and atherosclerosis. New York: Raven Press, 1984:165–74.

Sorted by citations

Items 801–900 of 999

The Ratio of High‐Density Lipoprotein Cholesterol to Apolipoprotein A‐I Predicts Myocardial Injury Following Elective Percutaneous Coronary Intervention
Li, X., Li, J., Guo, Y., Zhu, C., Qing, P., Wu, N., Xu, B., & Gao, R. (2014) · Clinical Cardiology · doi:10.1002/clc.22308 · Cited by 8
Antihyperlipidemic and Antioxidant Effects of the Mixture of Ginseng Radix and Crataegi Fructus: Experimental Study and Preliminary Clinical Results
Ko, C., Park, S.-U., Chang, G.-T., Jung, W., Moon, S., Park, J.-M., & Cho, K. (2011) · Journal of Ginseng Research · doi:10.5142/jgr.2011.35.2.162 · Cited by 8
Changes in Antioxidant Defense Capability and Lipid Profile after 12-Week Low- Intensity Continuous Training in Both Cigarette and Hookah Smokers: A Follow-Up Study
Koubaa, A., Triki, M., Trabelsi, H., Masmoudi, L., Sahnoun, Z., & Hakim, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0130563 · Cited by 8
Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer
Landrum, L. M., Zuna, R. E., & Walker, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40067-1.00004-8 · Cited by 8
The effect of weight loss on HDL subfractions and LCAT activity in two genotypes of APOA-II -265T>C polymorphism
Moradi, M., Mahmoudi, M., Saedisomeolia, A., Zahirihashemi, R., & Koohdani, F. (2017) · Nutrition Journal · doi:10.1186/s12937-017-0255-4 · Cited by 8
The Rise and Fall “ing” of the HDL Hypothesis
Feghaly, J., & Mooradian, A. D. (2020) · Drugs · doi:10.1007/s40265-020-01265-4 · Cited by 8
Lipids and lipoproteins
Donato, L. J., & Meeusen, J. W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815499-1.00028-4 · Cited by 8
Medical Management of Glaucoma
Barton, K., & Hitchings, R. A. (2013) · doi:10.1007/978-1-907673-44-3 · Cited by 8
Prediction of dietary adherence in cholesterol reduction: Relative contribution of personality variables and health attitudes
Lynch, D. J., Repka, F. J., Nagel, R. W., Birk, T., Gohara, A., Leighton, R. F., Walsh, M. E., & Weaver, M. T. (2000) · Psychology and Health · doi:10.1080/08870440008405584 · Cited by 8
Evidence of reduced plasma HDL subfractions in patients with cutaneous discoid lupus erythematosus
Lagogianni, I., Papapanagiotou, A., Piperi, C., Kalofoutis, C., Troupis, G., Zachari, A., & Kalofoutis, A. (2005) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.10.006 · Cited by 8
Immunonephelometric/turbidimetric apolipoprotein B assays for the clinical laboratory
Levinson, S. S., & Wagner, S. G. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90060-h · Cited by 8
Functionality of HDL particles: Heterogeneity and relationships to cardiovascular disease
Camont, L., Chapman, J., & Kontush, A. (2011) · Archives of Cardiovascular Diseases Supplements · doi:10.1016/s1878-6480(11)70784-4 · Cited by 8
Effect of glucocorticoid-free immunosuppressive protocol on serum lipids in renal transplant patients
Nowacka-Cieciura, E., Soluch, L., Cieciura, T., Lewandowska, D., Durlik, M., Shaibani, B., Serafinowicz, A., Szmidt, J., Rowinski, W. A., & Lao, M. (2000) · Transplantation Proceedings · doi:10.1016/s0041-1345(00)01251-3 · Cited by 8
Trend of lipid ratios associated with well known risk factors of coronary artery disease in different age: A population based study of 31,999 healthy individuals
Hatmi, Z. N., Mahdavi‐Mazdeh, M., Nazari, S. S. H., Hajighasemi, E., Heshmati, B. N., & Mahdavi, A. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.06.007 · Cited by 8
Dispêndio energético diário e níveis de lipídeos-lipoproteínas plasmáticos em adolescentes
Guedes, D. P., Guedes, J. E. R. P., Barbosa, D. S., & de Oliveira, J. A. (2007) · Revista Brasileira de Medicina do Esporte · doi:10.1590/s1517-86922007000200011 · Cited by 8
Zur altersabhängigen Verminderung von Lipoproteinen hoher Dichte (HDL) bei Frauen nach der Menopause
Chemnitius, J.-M., Winkel, H., Meyer, I., Schirrmacher, K., Armstrong, V. W., Kreuzer, H., & Zech, R. (1998) · Medizinische Klinik - Intensivmedizin und Notfallmedizin · doi:10.1007/bf03044831 · Cited by 8
Phenotype-genotype analyses of clinically diagnosed Malaysian familial hypercholestrolemic patients.
Al-Khateeb, A. M., Al-Talib, H. I., Mohamed, M. S., Yusof, Z., & Zilfalil, B. A. (2013) · PubMed · Cited by 8
High density- and beta-lipoprotein screening for risk of coronary artery disease in the context of new findings on reverse cholesterol transport.
Levinson, S. S. (2002) · PubMed · Cited by 8
Are Butter and Cheese Rich in Monounsaturates Beneficial in Hyperlipidaemic Patients?
O'Callaghan, D. J., Stanton, A. V., Rafferty, S., Canton, M., Murphy, J., Harrington, D., Connolly, B., & Horgan, J. (1996) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679600300505 · Cited by 8
Analysis of Apolipoproteins
Laker, M. F., & Evans, K. (1996) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/000456329603300102 · Cited by 8
Lipoprotein pattern in end‐stage renal disease and following successful renal transplantation
Banyai-Falger, S., Gottsauner‐Wolf, M., Stepan, E., Strobl, W., Jansen, M., Heinz, G., Hörl, W. H., & Derfler, K. (1997) · Clinical Transplantation · doi:10.1111/j.1399-0012.1997.tb01040.x · Cited by 8
Low high-density lipoprotein cholesterol and what to do about it
Kannel, W. B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90566-h · Cited by 8
Fibrates for secondary prevention of cardiovascular disease and stroke
Wang, D., Tao, W., Hao, Z., & Liu, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009580 · Cited by 10
Apolipoproteins in the Discrimination of Atherosclerotic Burden and Cardiac Function in Patients with Stable Coronary Artery Disease
Patel, J. V., Abraheem, A., Creamer, J., Gunning, M., Hughes, E., & Lip, G. Y. H. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfp202 · Cited by 7
Effects of heavy alcohol intake on lipoproteins, adiponectin and cardiovascular risk
Kuusisto, S. M. (2014) · Cited by 7
Association of HDL cholesterol with all-cause and cardiovascular mortality in primary hypercholesterolemia
Bea, A. M., González-Guerrero, A., Cenarro, A., Lamíquiz-Moneo, I., Climent, E., Jarauta, E., Gracia‐Rubio, I., Benaiges, D., Laclaustra, M., Tejedor, M. T., et al. (2024) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2024.118617 · Cited by 7
Lipídeos séricos e morfologia hepática de ratos alimentados com diferentes fontes lipídicas (óleo de soja, gordura de peixe e porco, margarina e manteiga)
de Almeida, M. E. F., de Queiróz, J. H., Costa, N. M. B., & da Matta, S. L. P. (2011) · Revista de Nutrição · doi:10.1590/s1415-52732011000100014 · Cited by 7
Increased Non-High-Density Lipoprotein Cholesterol in Children and Young Adults with Turner Syndrome Is Not Explained By BMI Alone
Kelley, J. C., Gutmark‐Little, I., Backeljauw, P. F., & Bamba, V. (2017) · Hormone Research in Paediatrics · doi:10.1159/000477761 · Cited by 7
HDL subgroups and their paraoxonase‐1 activity in the obese, overweight and normal weight subjects
Doğan, K., Şeneş, M., Karaca, A., Kayalp, D., Kan, S., Gülçelik, N. E., Aral, Y., & Yücel, D. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14969 · Cited by 7
Cardiac Markers
French, D., & Wu, A. H. B. (2013) · Elsevier eBooks · doi:10.1016/b978-0-08-097037-0.00066-x · Cited by 7
Long-term use of depot-norethisterone enanthate: Effect on blood lipid fractions
McEwan, J. A., Griffin, M., Fotherby, K., & Trayner, I. (1992) · Contraception · doi:10.1016/0010-7824(92)90131-c · Cited by 7
Reflex testing I: Algorithm for lipid and lipoprotein measurement in coronary heart disease risk assessment
Wu, A. H. B., Contois, J. H., & Cole, T. G. (1999) · Clinica Chimica Acta · doi:10.1016/s0009-8981(98)00185-5 · Cited by 7
Trans Polyunsaturated Fatty Acid Contents in Brazilian Refined Soybean Oil
Martin, C. A., Visentainer, J. V., Oliveira, C. C., Matsushita, M., & de Souza, N. E. (2006) · Analytical Sciences · doi:10.2116/analsci.22.631 · Cited by 7
Apolipoprotein A-II Levels and Coronary Artery Disease in Subjects With and Without Diabetes: A Study With Use of a Specific Radioimmunoassay for Apolipoprotein A-II
Wentworth, M., O’Brien, T., Rastogi, A., & Kottke, B. A. (1993) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)60369-3 · Cited by 7
Reverse cholesterol transport: relationship between free cholesterol uptake and HDL3 in normolipidaemic and hyperlipidaemic subjects
Cabezas, M. C., van Heusden, G. P. H., de Bruin, T. W., van Beckhoven, J. R. C. M., Kock, L. A., WTRTZ, K. W. A., & Erkelens, D. W. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00751.x · Cited by 7
Patients with low levels of high-density lipoprotein cholesterol: to treat or not to treat?
Tavintharan, S., Sc, L., & Cf, S. (2005) · PubMed · Cited by 7
Alcohol and the heart
Sheehy, T. W. (1992) · Postgraduate Medicine · doi:10.1080/00325481.1992.11701294 · Cited by 7
High-Density Lipoprotein Cholesterol
Gotto, P. P. T. A. A. M. (2013) · CRC Press eBooks · doi:10.3109/9781420019667-14 · Cited by 7
A Votre Santé
Kreisberg, R. A. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400140017005 · Cited by 7
Apolipoproteins and coronary heart disease
Schaefer, E. J. (1994) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1994.tb02372.x · Cited by 7
Effect of simvastatin on high density lipoprotein subfractions and apolipoproteins in Type IIa hypercholesterolemia
Crook, D., Bruce, R., Worthington, M., Mulcahy, D., Patterson, D., & Wynn, V. (1992) · Cardiovascular Drugs and Therapy · doi:10.1007/bf00052565 · Cited by 7
Effects of herbal acupuncture(Atratylodes japonica, Coix lachrymajobi, Ephedra sinica, Atratylodes japonica mixed with Coix lachrymajobi and Ephedra sinica mixed with Green tea) at Pungnyung(ST40) and Umnungchon(SP9) in obese Rats induced by high fat diet
Youn, D.-H., Kang, J.-D., Joo, J.-S., Chae, W.-S., & Na, C.-S. (2004) · Journal of pharmacopuncture · doi:10.3831/kpi.2004.7.1.087 · Cited by 6
Prognostic Value of Apolipoprotein B and A-I in the Prediction of Myocardial Infarction in Middle-Aged Men and Women: Results From the MONICA/KORA Augsburg Cohort Study
Meisinger, C., Loewel, H., Wilfried, M. R. A. Z., & Köenig, W. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.05.032 · Cited by 6
Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
Viljoen, A., & Wierzbicki, A. S. (2010) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s7302 · Cited by 6
Comparing the Sensory Characteristics of Doughnuts Made WithTrans-Fat-Free Canola Shortening,Trans-Fat-Free Palm Shortening, andTrans-Fat Vegetable/Soybean Shortening
Bordi, P. L., Snyder, K. S., & Hessert, S. W. (2010) · Journal of Culinary Science & Technology · doi:10.1080/15428052.2010.494533 · Cited by 6
High-density lipoprotein subfractions in normolipidemic individuals without clinical atherosclerosis lipoprotein subfractions in an adult population
Sodré, F. L., Castanho, V. S., Castilho, L. N., de Barros-Mazon, S., & de Faria, E. C. (2006) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20111 · Cited by 6
Nutrition, sensory evaluation, and performance analysis of hydrogenated frying oils
Hack, D. M., Bordi, P. L., & Hessert, S. W. (2009) · International Journal of Food Sciences and Nutrition · doi:10.3109/09637480802011128 · Cited by 6
Prevention of cardiovascular disease and fermented alcoholic beverages. Reality or fiction?
Meseguer, E. S., Anglès, I. S., Rodríguez, R. C., Esmel, E. V., & Barquero, S. C. (2019) · Nutrición Hospitalaria · doi:10.20960/nh.02811 · Cited by 6
Mutu Minyak Jelantah Dengan Adsorben Biji Salak (Salacca zalacca (Gaertn.)Voss) menggunakan Parameter Bilangan Peroksida dan Asam Lemak Bebas
Ihwan, I., Fadlia, F., & Anam, S. (2019) · Jurnal Farmasi Galenika (Galenika Journal of Pharmacy) (e-Journal) · doi:10.22487/j24428744.0.v0.i0.10070 · Cited by 6
Elevation of high-density lipoprotein cholesterol in humans during long-term therapy with amiodarone
Pollak, P. T., & Tan, M. H. (1999) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00846-7 · Cited by 6
Preventing, stopping, or reversing coronary artery disease— triglyceride-rich lipoproteins and associated lipoprotein and metabolic abnormalities: The need for recognition and treatment
Ferguson, E. E. (2000) · Disease-a-Month · doi:10.1016/s0011-5029(00)90011-7 · Cited by 6
High‐Density Lipoprotein Cholesterol: A Potential Therapeutic Target for Prevention of Coronary Artery Disease
Chernobelsky, A., Ashen, M. D., Blumenthal, R. S., & Coplan, N. L. (2007) · Preventive Cardiology · doi:10.1111/j.1520-037x.2007.05512.x · Cited by 6
Achieving confidence in mechanism for drug discovery and development
Pitluk, Z., & Khalil, I. G. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.10.001 · Cited by 6
High-Density Lipoprotein as a Key Component in the Prevention of Premature Atherosclerotic Disease in the Insulin Resistance Syndrome
Hansel, B., Kontush, A., & Twickler, M. (2004) · Seminars in Vascular Medicine · doi:10.1055/s-2004-835381 · Cited by 6
Characteristics Associated with Differences in Reported Versus Measured Total CholesterolAmong Male Physicians
Scranton, R. E., Sesso, H. D., Glynn, R. J., Levenson, J. W., Stedman, M. R., GAGNON, D. R., & Gaziano, J. M. (2005) · The Journal of Primary Prevention · doi:10.1007/s10935-004-0991-z · Cited by 6
Alternative Prevention and Treatment of Cardiovascular Disease Part 1
Pratt, C. (2010) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2010.02.009 · Cited by 6
Genetische Risikofaktoren für den Myokardinfarkt
Walter, D. H., & Zeiher, A. M. (2000) · Herz · doi:10.1007/bf03044119 · Cited by 6
Cardiovascular Disease
Schulte, P. A., Rothman, N., & Austin, M. A. (1993) · Elsevier eBooks · doi:10.1016/b978-0-12-632345-0.50017-1 · Cited by 6
Ljpoprotein-containlng apolipoprotein A-l: sex-related quantitative and qualitative changes in this lipoprotein subspecies after ingestion of fat
Ohta, T., Ikeda, Y., Nakamura, R., & Matsuda, I. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.2.404 · Cited by 6
Design and synthesis of tricyclic derivatives as high density lipoprotein cholesterol enhancers
Elokdah, H. M., Chai, S., Ho, D. M., & Sulkowski, T. S. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00668-5 · Cited by 6
Treatment of severe hypercholesterolemia with heparin-induced LDL apheresis
Richter, W. O., Jacob, B. G., Ritter, M. M., Sühler, K., Vierneisel, K., & SCHWANDT, P. (1992) · Current Therapeutic Research · doi:10.1016/s0011-393x(05)80483-7 · Cited by 6
Nonpharmacologic and pharmacologic treatment of patients with low levels of high-density lipoprotein cholesterol
Bowen, P., & Guyton, J. R. (2000) · Current Atherosclerosis Reports · doi:10.1007/s11883-000-0095-z · Cited by 6
Statins, high-density lipoprotein, and the low-density lipoprotein/high-density lipoprotein ratio11Letters (from the United States) concerning a particular article in The American Journal of Cardiology® must be received within 2 months of the article’s publication, and should be limited (with rare exceptions) to 2 double-spaced typewritten pages. Two copies must be submitted.
Silva, J. M. (2000) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01184-x · Cited by 6
Dietary fibre, exercise and serum lipids and lipoprotein cholesterols in 12 to 15 year olds
Morley, R., Baker, B. A., Greene, L., Livingstone, M., Harland, P., & Lucas, A. (1998) · Acta Paediatrica · doi:10.1080/080352598750030889 · Cited by 6
Regulation of the Quantity and Quality of High-Density Lipoproteins by Alcohol
Hannuksela, M. L., & Savolainen, M. J. (2001) · CRC Press eBooks · doi:10.3109/9780203902172-29 · Cited by 6
Efficacy of Exercise Time Models in Weight-Loss and Coronary Risk Panel of Middle-Aged Females
Rezaeipour, M., & Leonidovich, A. G. (2018) · Bimonthly Journal of Hormozgan University of Medical Sciences · doi:10.5812/hmj.86318 · Cited by 5
The correlation of some of the heating of various palm oils to histologic and liver function of rats (Rattus norvegicus)
Ilyas, S. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1116/5/052032 · Cited by 5
Endometrial Hyperplasia, Estrogen Therapy, and the Prevention of Endometrial Cancer
Landrum, L. M., Zuna, R. E., & Walker, J. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-323-07419-3.00004-7 · Cited by 5
A homogeneous assay to determine high-density lipoprotein subclass cholesterol in serum
Matsushima‐Nagata, K., Sugiuchi, H., Anraku, K., Takao, T., Kondo, Y., Ishitsuka, Y., Irikura, M., Irie, T., Matsumura, T., Araki, E., et al. (2020) · Analytical Biochemistry · doi:10.1016/j.ab.2020.114019 · Cited by 5
High-Density Lipoproteins
Toth, P. P. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-533-6_9 · Cited by 5
Common Variation in Genes Involved in HDL Metabolism Influences Coronary Heart Disease Risk at the Population Level
Brousseau, M. E. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045106.90301.26 · Cited by 5
Making practical sense of clinical trial data in decreasing cardiovascular risk
Castelli, W. P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)01872-0 · Cited by 5
Serum Lipoprotein Patterns in Long-Term Anabolic Steroid Users
Sachtleben, T. R., Berg, K. E., Cheatham, J. P., Felix, G. L., & Hofschire, P. J. (1997) · Research Quarterly for Exercise and Sport · doi:10.1080/02701367.1997.10608873 · Cited by 5
Screening for Cardiovascular Risk: Cost-Benefit Considerations in a Comparison of Total Cholesterol Measurements and Two Compound Blood Lipid Indices
Berg, J. E. (1995) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1177/174182679500200509 · Cited by 5
Alcohol and the J‐curve survival
Cullen, K. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb01736.x · Cited by 5
Trans Fat Formation and Lipid Oxidation in Palm Olein during Prolonged Thermal Treatments
Vu, P. T., & Boonyarattanakalin, S. (2013) · Journal of Medical and Bioengineering · doi:10.12720/jomb.2.3.214-217 · Cited by 5
The effects of tamoxifen on the endometrium, blood flow of the uterine arteries and serum lipoprotein (a) levels in postmenopausal women
Kontostolis, E., Stefanidis, K., Navrozoglou, I., Mouzakioti, E., Paschopoulos, M. E., & Lolis, D. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809015543 · Cited by 5
Measuring serum total cholesterol: do vascular surgeons know what they are doing?
Wijesinghe, L. D., Gamage, L., Berridge, D., & Scott, D. J. A. (1999) · PubMed Central · Cited by 5
The role of fibric acid derivatives in the secondary prevention of coronary heart disease
Krakoff, J. A., Vela, B. S., & Brinton, E. A. (2000) · Current Cardiology Reports · doi:10.1007/s11886-000-0060-z · Cited by 5
“Isolated” Low High-Density Lipoprotein Cholesterol
Wilt, V. M., & Gums, J. G. (1997) · Annals of Pharmacotherapy · doi:10.1177/106002809703100115 · Cited by 5
Cholesterol, Apolipoproteins, and the Risk of Myocardial Infarction
Crook, D., Godsland, I., & Wynn, V. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202133260715 · Cited by 5
A influência dos ácidos graxos trans na disfunção da célula endotelial e o possível efeito terapêutico do exercício sobre o tecido endotelial como forma de prevenção ou regressão da aterosclerose
Masi, L. N., & Silva, É. P. P. (2009) · Jornal Vascular Brasileiro · doi:10.1590/s1677-54492009000200012 · Cited by 3
Update of HDL in atherosclerotic cardiovascular disease
Schoch, L., Alcover, S., Padró, T., Ben‐Aicha, S., Mendieta, G., Badimón, L., & Vilahur, G. (2023) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2023.11.001 · Cited by 4
Assessment of Serum Atherogenic Indices and Insulin Resistance in Retinal Vein Occlusion
Gönül, Ş., & Eker, S. (2024) · Turkish Journal of Ophthalmology · doi:10.4274/tjo.galenos.2024.66367 · Cited by 4
Oxidized low-density lipoproteins and their contribution to atherosclerosis
Babakr, A. T. (2024) · Reviews on Clinical Pharmacology and Drug Therapy · doi:10.17816/rcf633567 · Cited by 6
High-density lipoprotein subfractions and influence of endothelial lipase in a healthy Turkish population: A study in a land of low high-density lipoprotein cholesterol
Kılıç, H., Atalar, E., Lay, İ., Yazıhan, N., Büyükçam, F., Saygısunar, U., Aksoy, M., Gündüz, H., & Akdemir, R. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2013.879992 · Cited by 4
Genetic Variation in 9p21 and the Plasma Proteome
Mahdavi, S., Jenkins, D. J. A., Borchers, C. H., & El‐Sohemy, A. (2018) · Journal of Proteome Research · doi:10.1021/acs.jproteome.8b00117 · Cited by 4
Cohort Profiles: what are they good for?
Ebrahim, S. B. J. (2021) · International Journal of Epidemiology · doi:10.1093/ije/dyab054 · Cited by 4
The Effects of Dietary Fatty Acids on Lipid Metabolism
Vemuri, M., & Kelley, D. S. (2007) · Food science and technology · doi:10.1201/9781420006902.ch23 · Cited by 4
Dyslipidemia and atherogenic indexes in children with transfusion-dependent thalassemia
Ray, S., Saikia, D., Vashisht, Y., Sharma, S., Meena, R. K., & Kumar, M. (2023) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2023.02.006 · Cited by 4
Chapter 23. New Potential Therapies for the Treatment of Atherosclerosis
Larsen, S. D., & Spilman, C. H. (1993) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(08)60893-3 · Cited by 4
[CONSUMPTION OF CHEESE AND MILK AND CHRONIC DISEASES ASSOCIATED WITH OBESITY, FRIEND OR FOE?].
Durán‐Agüero, S., Torres, J., & Catalán, J. S. (2015) · PubMed · doi:10.3305/nh.2015.32.1.8982 · Cited by 4
HDL-Cholesterol: Exercise Formula. Results of Long-Term (6-Year) Strenuous Swimming Exercise in a Middle-Aged Male with Paraplegia
Sorg, R. J. (1993) · Journal of Orthopaedic and Sports Physical Therapy · doi:10.2519/jospt.1993.17.4.195 · Cited by 4
Treating low HDL—From bench to bedside
Ng, D. S. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.04.005 · Cited by 4
Nutrition, Sensory Evaluation, and Performance Analysis of Trans fat-Free, Low Alpha-Linolenic Acid Frying Oils
Hack, D. M., Bordi, P. L., & Hessert, S. W. (2009) · Journal of Foodservice Business Research · doi:10.1080/15378020802672030 · Cited by 4
Targeting High-Density Lipoprotein Cholesterol in the Management of Cardiovascular Disease
Davidson, M. H. (2007) · The American Heart Hospital Journal · doi:10.1111/j.1541-9215.2007.07423.x · Cited by 4
Cholesteryl Ester Transfer Protein B1B1 Genotype Is Associated with a Parental History of Cardiovascular Diseases in Taiwanese People
Hsieh, M., Chen, C.-C., Wang, J., Chong, I., Yhe, C.-J., Shin, S., & Lin, S. (2008) · Medical Principles and Practice · doi:10.1159/000112969 · Cited by 4
Synthesis of Novel New 2-(2-(4-((3,4-Dihydro-4-oxo-3-aryl quinazolin-2-yl)methyl)piperazin-1-yl)acetoyloxy)-2-phenyl Acetic Acid Esters
Acharyulu, P. V. R., Dubey, P. K., Reddy, P. V. V. P., & Suresh, T. (2009) · Synthetic Communications · doi:10.1080/00397910902735381 · Cited by 4
HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigm
Shah, S. (2006) · Future Lipidology · doi:10.2217/17460875.1.1.55 · Cited by 4
Racial Disparities between the Sex Steroid Milieu and the Metabolic Risk Profile
PERRY, A. C., Wang, X., Goldberg, R., Ross, R., & Jackson, L. (2010) · Journal of Obesity · doi:10.1155/2010/174652 · Cited by 4

Authors: Stampfer, M. J., Sacks, F. M., Salvini, S., Willett, W. C., & Hennekens, C. H.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Stampfer, Meir J.
Sacks, Frank M.
Willett, Walter C.
Hennekens, Charles H.
Venue: New England Journal of Medicine
Publisher: Massachusetts Medical Society
Published: 1991-08-08
Volume: 325
Issue: 6
Pages: 373-381
ISSN: 0028-4793 (ISSN-L)
1533-4406
DOI: 10.1056/nejm199108083250601
OpenAlex: W2337032743
Cited by: 1,163
References: 56
Citations by year: 2026: 6 · 2025: 5 · 2024: 10 · 2023: 10 · 2022: 7 · 2021: 12 · 2020: 14 · 2019: 12 · 2018: 18 · 2017: 17 · 2016: 24 · 2015: 31 · 2014: 34 · 2013: 33 · 2012: 31
FWCI: 80.75
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: New England Journal of Medicine (publishedVersion)
PubMed (publishedVersion)
Funders: National Heart, Lung, and Blood Institute (HL-34595, HL 26490, R01HL034595)
National Cancer Institute (R01CA042182, CA 42182)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
Keywords: myocardial infarction, HDL cholesterol, HDL2, HDL3, apolipoprotein B-100, apolipoprotein A-I, apolipoprotein A-II, TC/HDL-C ratio, cardiovascular risk prediction, total cholesterol, men, Physicians' Health Study, lipoprotein subfractions, risk factors, coronary heart disease prevention, statin therapy
MeSH terms: Adult, Aged, Aged, 80 and over, Apolipoproteins, Apolipoproteins A, Apolipoproteins B, Cholesterol, Humans, Cholesterol, HDL, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks